PM-1017

N/A

Report date: 2024/03/07 17:59:02

Base Information

Drug NamePM-1017

Drug Alias NamePM-1017PM1017

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionInterleukin-5 inhibitorsAnti-Interleukin-4 receptor subunit alpha

TargetsInterleukin-5Interleukin-4 receptor subunit alpha

Therapy Area/IndicationsAsthma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator Companies +[1] N/A

China Registration ClassN/A

Develop Information

Active Companies +[1] N/A

Inactive CompaniesN/A

Active IndicationsAsthma

Inactive IndicationsN/A

Other Information

ATC CodeN/A